Related Experiment Videos
HLA-B*15 diversity in the Korean population
1Department of Clinical Pathology, College of Medicine, Hallym University, Seoul, Korea. leekw@www.hallym.or.kr
Tissue Antigens
|January 6, 2001
Summary
Human Leukocyte Antigen (HLA)-B*15 alleles are diverse in Koreans, with B*1501 being most common. This genetic diversity impacts hematopoietic stem cell donor selection and DNA typing strategies for B15/B70 positive individuals.
Area of Science:
- Immunogenetics
- Human Leukocyte Antigen (HLA) complex
- Population genetics
Background:
- HLA-B*15 alleles present challenges in routine clinical typing due to serologic cross-reactivity.
- Over 25% of Koreans express HLA-B molecules encoded by HLA-B*15 alleles, necessitating further characterization.
Purpose of the Study:
- To characterize the diversity of HLA-B*15 alleles in a Korean population.
- To identify specific HLA-B*15 alleles and their frequencies.
- To investigate associations between HLA-B*15 alleles and other HLA loci.
Main Methods:
- Utilized B*15-specific polymerase chain reaction (PCR) and sequence-specific oligonucleotide probe (SSOP) hybridization.
- Analyzed DNA samples from 237 serologically B15/B70 positive Korean individuals.
- Employed 39 digoxigenin-labeled probes for precise allele identification.
Main Results:
- Identified nine distinct HLA-B*15 alleles, with B*1501 (64.8%), B*1511 (14.1%), B*1507 (8.6%), and B*1518 (5.5%) being the most frequent.
- Discovered that B62 molecules, encoded by four alleles, could not be differentiated by serologic methods.
- Revealed that eight of fifteen apparent B15/B70 homozygotes were actually heterozygotes for different B*15 alleles.
- Observed strong associations between specific B*15 alleles and HLA-Cw, DRB1, and A types (e.g., B*1507-Cw3, B*1507-DRB1*04, B*1507-A24).
Conclusions:
- Confirmed significant HLA-B*15 allele diversity within the Korean population.
- Highlighted the limitations of serologic typing for certain HLA-B*15 alleles.
- Emphasized the utility of these findings for optimizing hematopoietic stem cell donor searches and DNA typing strategies in this population.